180 Life Sciences Corp. (ATNF)

180 Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4.59	1.98	6.97	8.22	2.11
Cash & Short-Term Investments	4.59	1.98	6.97	8.22	2.11
Cash Growth	132.06%	-71.65%	-15.25%	290.06%	2428.32%
Other Receivables	0.04	0.45	0.62	0.69	0.78
Receivables	0.04	0.45	0.62	0.69	0.78
Prepaid Expenses	0.52	1.21	1.34	2.28	1.12
Total Current Assets	5.14	3.64	8.93	11.2	4.01
Goodwill	-	-	-	36.99	36.9
Other Intangible Assets	7.62	1.62	1.66	1.95	2.05
Long-Term Deferred Charges	-	-	9.06	12.58	12.57
Total Assets	12.76	5.26	19.65	62.71	55.53
Accounts Payable	2.62	2.16	1.8	0.59	8.53
Accrued Expenses	0.44	1.82	2.35	1.68	4.78
Short-Term Debt	0.13	1.02	1.3	1.86	3.66
Current Portion of Long-Term Debt	0.01	0.01	0.01	0.05	0.01
Other Current Liabilities	0.3	0.05	0.2	15.52	4.44
Total Current Liabilities	3.5	5.06	5.66	19.7	21.42
Long-Term Debt	0.01	0.02	0.03	0.05	0.11
Long-Term Deferred Tax Liabilities	-	0.3	2.62	3.64	3.67
Other Long-Term Liabilities	-	-	-	-	0.04
Total Liabilities	3.51	5.39	8.31	23.39	25.25
Common Stock	0	0	0	0	0
Additional Paid-In Capital	153.69	130.12	121.64	107.19	78.01
Retained Earnings	-141.52	-127.34	-107.41	-68.68	-48.36
Comprehensive Income & Other	-2.92	-2.9	-2.89	0.82	0.64
Total Common Equity	9.25	-0.13	11.34	39.32	30.29
Shareholders' Equity	9.25	-0.13	11.34	39.32	30.29
Total Liabilities & Equity	12.76	5.26	19.65	62.71	55.53
Total Debt	0.15	1.05	1.34	1.96	3.78
Net Cash (Debt)	4.43	0.92	5.63	6.27	-1.67
Net Cash Growth	380.68%	-83.63%	-10.16%	-	-
Net Cash Per Share	4.84	2.43	56.29	75.95	-35.02
Filing Date Shares Outstanding	5.19	0.85	0.2	0.09	0.08
Total Common Shares Outstanding	3.18	0.53	0.2	0.09	0.07
Working Capital	1.64	-1.42	3.27	-8.5	-17.41
Book Value Per Share	2.91	-0.24	57.52	439.03	439.76
Tangible Book Value	1.63	-1.75	9.69	0.39	-8.66
Tangible Book Value Per Share	0.51	-3.27	49.11	4.31	-125.77

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q